Aarti Drugs
AARTIDRUGS · Pharma > Pharmaceuticals & Drugs · Chairman: Prakash M Patil · MD: Rashesh C Gogri · Listing date: Sept. 12, 1996 · Employees: 1620 · Mumbai · http://www.aartidrugs.co.in

Stock Price vs Company Growth
1d
0.8%
1w
2.6%
1m
6.7%
3m
19.2%
6m
7.2%
1y
5.7%
5y
28.9%
10y
16.6%
all
27.2%

Use @ for users, # for companies and : for emojis
 
 
 
 
Last Traded Price

₹ 456 0.8%
450
635
Company Overview

Sales
2,380 Cr
Growth: -9.1%
Profit after Tax
152 Cr
Growth: -2.9%
Small Cap
4,160 Cr
P/E: 27.5x
Industry P/E: 36.0x
Fundamentals

Sales (Cr) ₹ 2,380
Growth -9.1%
EBITDA 12.1%
P/S 1.7x
Dividend 0.2%
P/E 27.5x
Book Value ₹ 10
PEG Ratio -3.0x
ROE 165.9%
P/B N/A
Shareholding Pattern

Institutions
Harit Pragji Shah
2.65 %
Jayshree Harit Shah
1.79 %
Dsp Small Cap Fund
1.21 %
Promoters
Prakash Moreshwar Patil
9.1 %
Seema Harshit Savla
4.92 %
Harshit Manilal Savla
4.73 %
Rashesh Chandrakant Gogri
4.52 %
Priti Prakash Patil
4.4 %
Others
Iepf
0.3 %
Llp
0.08 %
Increase    Decrease    No change
Company Profile Detailed

The company is engaged in the manufacturing of Active Pharmaceutical Ingredients (APIs), Pharma Intermediates, Specialty Chemicals and also produces Formulations with its wholly-owned subsidiary - Pinnacle Life Science Private Limited. Products under APIs includes Ciprofloxacin Hydrochloride, Metronidazole, Metformin HCL, Ketoconazole, Ofloxacin etc. whereas Specialty Chemicals includes Benzene Sulphonyl Chloride, Methyl Nicotinate etc.
Investors (90)
Followers (7)